{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:12:30Z","timestamp":1718219550900},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T00:00:00Z","timestamp":1396051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11046-014-9738-4","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T14:04:51Z","timestamp":1396015491000},"page":"143-156","source":"Crossref","is-referenced-by-count":4,"title":["In Vitro Susceptibility of Candida Isolates from Organ Transplant Recipients to Newer Antifungals"],"prefix":"10.1007","volume":"177","author":[{"given":"Alexandra","family":"Geusau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Antoniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Poitschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Presterl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Willinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,29]]},"reference":[{"issue":"24","key":"9738_CR1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","volume":"338","author":"JA Fishman","year":"1998","unstructured":"Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"9738_CR2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","volume":"10","author":"R Patel","year":"1997","unstructured":"Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997;10(1):86\u2013124.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"9738_CR3","first-page":"385","volume":"3","author":"P Badiee","year":"2005","unstructured":"Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendy H, Mahmoody M. Fungal infections in solid organ recipients. Exp Clin Transpl. 2005;3(2):385\u20139.","journal-title":"Exp Clin Transpl"},{"issue":"5","key":"9738_CR4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkg450","volume":"52","author":"J Fortun","year":"2003","unstructured":"Fortun J, Martin-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother. 2003;52(5):813\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"9738_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","volume":"52","author":"C Lass-Florl","year":"2009","unstructured":"Lass-Florl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses. 2009;52(3):197\u2013205.","journal-title":"Mycoses"},{"issue":"4","key":"9738_CR6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/432060","volume":"41","author":"M Nucci","year":"2005","unstructured":"Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005;41(4):521\u20136.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"9738_CR7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10096-009-0730-8","volume":"28","author":"L Antoniewicz","year":"2009","unstructured":"Antoniewicz L, Relijc D, Poitschek C, Presterl E, Geusau A. Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis. 2009;28(8):945\u201357. doi: 10.1007\/s10096-009-0730-8 .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9738_CR8","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition","author":"CLSI","year":"2008","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. Wayne: Clinical and Laboratory Standards Institute; 2008."},{"issue":"1 Suppl","key":"9738_CR9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125(1 Suppl):S3\u201313. doi: 10.1016\/j.amjmed.2011.11.001 .","journal-title":"Am J Med"},{"issue":"8","key":"9738_CR10","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol. 2013;51(8):2571\u201381. doi: 10.1128\/JCM.00308-13 .","journal-title":"J Clin Microbiol"},{"issue":"6","key":"9738_CR11","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/JCM.02434-08","volume":"47","author":"SA Messer","year":"2009","unstructured":"Messer SA, Moet GJ, Kirby JT, Jones RN. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006\u20132007). J Clin Microbiol. 2009;47(6):1942\u20136.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"9738_CR12","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11):3435\u201342. doi: 10.1128\/JCM.01283-12 .","journal-title":"J Clin Microbiol"},{"issue":"7","key":"9738_CR13","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/JCM.42.7.3117-3119.2004","volume":"42","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates. J Clin Microbiol. 2004;42(7):3117\u20139.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"9738_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7326\/ACPJC-2008-148-1-015","volume":"148","author":"J Gea-Banacloche","year":"2008","unstructured":"Gea-Banacloche J. Anidulafungin was noninferior to fluconazole for invasive candidiasis. ACP J Club. 2008;148(1):15.","journal-title":"ACP J Club"},{"issue":"12","key":"9738_CR15","first-page":"1249","volume":"6","author":"N Scheinfeld","year":"2007","unstructured":"Scheinfeld N. A review of the new antifungals: posaconazole, micafungin, and anidulafungin. J Drugs Dermatol. 2007;6(12):1249\u201351.","journal-title":"J Drugs Dermatol"},{"issue":"24","key":"9738_CR16","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","volume":"356","author":"AC Reboli","year":"2007","unstructured":"Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med. 2007;356(24):2472\u201382.","journal-title":"N Engl J Med"},{"issue":"12","key":"9738_CR17","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"BD Alexander","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56(12):1724\u201332. doi: 10.1093\/cid\/cit136 .","journal-title":"Clin Infect Dis"},{"issue":"2","key":"9738_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/42.2.241","volume":"42","author":"D Sanglard","year":"1998","unstructured":"Sanglard D, Ischer F, Koymans L, Bille J. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother. 1998;42(2):241\u201353.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9738_CR19","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"M Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"9738_CR20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1469-0691.2007.01812.x","volume":"13","author":"E Presterl","year":"2007","unstructured":"Presterl E, Daxbock F, Graninger W, Willinger B. Changing pattern of candidaemia 2001\u20132006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect. 2007;13(11):1072\u20136.","journal-title":"Clin Microbiol Infect"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-014-9738-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9738-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:29:39Z","timestamp":1648704579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-014-9738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,29]]},"references-count":20,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["9738"],"URL":"https:\/\/doi.org\/10.1007\/s11046-014-9738-4","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,29]]}}}